Citigroup Inc (NYSE:C) posted its earnings results on Monday. The financial services provider reported $1.83 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.78 by $0.05, Morningstar.com reports. The firm had revenue of $18.76 billion during the quarter, compared to analysts’ expectations of $18.49 billion. Citigroup had a net margin of 18.32% and a return on equity of 10.05%. The company’s revenue was up 1.6% compared to the same quarter last year. During the same period in the previous year, the company earned $1.63 earnings per share.
C opened at $71.71 on Tuesday. Citigroup Inc has a fifty-two week low of $48.42 and a fifty-two week high of $75.24. The company has a debt-to-equity ratio of 1.36, a current ratio of 1.01 and a quick ratio of 1.01. The business’s fifty day simple moving average is $67.94. The firm has a market capitalization of $165.97 billion, a P/E ratio of 10.78, a P/E/G ratio of 0.81 and a beta of 1.74.
In other news, CEO Stephen Bird sold 30,000 shares of the business’s stock in a transaction on Monday, April 22nd. The shares were sold at an average price of $69.33, for a total value of $2,079,900.00. The sale was disclosed in a filing with the SEC, which is available at this link. 0.09% of the stock is owned by insiders.
A number of hedge funds and other institutional investors have recently modified their holdings of C. LFA Lugano Financial Advisors SA bought a new stake in shares of Citigroup in the 1st quarter valued at about $27,000. Harvest Group Wealth Management LLC bought a new stake in shares of Citigroup in the 1st quarter valued at about $28,000. Centaurus Financial Inc. increased its stake in shares of Citigroup by 95.1% in the 1st quarter. Centaurus Financial Inc. now owns 1,713 shares of the financial services provider’s stock valued at $28,000 after acquiring an additional 835 shares during the last quarter. Avestar Capital LLC increased its stake in shares of Citigroup by 35.0% in the 1st quarter. Avestar Capital LLC now owns 610 shares of the financial services provider’s stock valued at $33,000 after acquiring an additional 158 shares during the last quarter. Finally, Farmers National Bank bought a new stake in shares of Citigroup in the 1st quarter valued at about $34,000. Institutional investors and hedge funds own 75.98% of the company’s stock.
A number of equities analysts have recently commented on the stock. ValuEngine lowered shares of Acceleron Pharma from a “strong-buy” rating to a “buy” rating in a research report on Thursday, April 18th. Bank of America reaffirmed a “buy” rating and set a $78.00 target price on shares of Citigroup in a research report on Monday. Oppenheimer set a $15.00 target price on shares of Strongbridge Biopharma and gave the stock a “buy” rating in a research report on Tuesday, March 26th. HSBC reaffirmed a “hold” rating on shares of Societe Generale in a research report on Thursday, April 4th. Finally, Goldman Sachs Group raised shares of UCB S A/ADR from a “neutral” rating to a “buy” rating in a research report on Thursday, May 30th. Four research analysts have rated the stock with a hold rating and eighteen have given a buy rating to the company. The company has an average rating of “Buy” and a consensus target price of $79.23.
Citigroup Company Profile
Citigroup Inc, a diversified financial services holding company, provides various financial products and services for consumers, corporations, governments, and institutions in North America, Latin America, Asia, Europe, the Middle East, and Africa. The company operates through two segments, Global Consumer Banking (GCB) and Institutional Clients Group (ICG).
Featured Article: Certificate of Deposit (CD) For Risk Adverse Investors?
Receive News & Ratings for Citigroup Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Citigroup and related companies with MarketBeat.com's FREE daily email newsletter.